Exploiting human T_regs’ sweet tooth to improve cancer immunotherapy

Article Tools

• Email

  Thank you for your interest in spreading the word about Science Translational Medicine.

  NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

  Your Email

  Your Name

  Send To

  Enter multiple addresses on separate lines or separate them with commas.

  You are going to email the following Exploiting human Tregs’ sweet tooth to improve cancer immunotherapy

  Message Subject (Your Name) has forwarded a page to you from Science Translational Medicine

  Message Body (Your Name) thought you would like to see this page from the Science Translational Medicine web site.

  Your Personal Message

  Send Message
• Save to my folders

  Log In with your AAAS Login

   

• Alerts

  Please log in to add an alert for this article.

  Log In with your AAAS Login

   

  Sign In to Email Alerts with your Email Address

  Email

  Log in
• Citation tools

  Exploiting human T_regs’ sweet tooth to improve cancer immunotherapy

  By Hu Zeng

  Science Translational Medicine07 Nov 2018

  TLR8 activation enhances cancer immunotherapy by reprograming of glucose metabolism in regulatory T cells.

  Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
• Share

  Exploiting human T_regs’ sweet tooth to improve cancer immunotherapy

  By Hu Zeng

  Science Translational Medicine07 Nov 2018

  TLR8 activation enhances cancer immunotherapy by reprograming of glucose metabolism in regulatory T cells.

  Share This Article: Copy